//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
🧪 A new study led by Dr. Janani Durairaj and Prof. Torsten Schwede shows that current AI models in drug discovery still face limitations. Learn more👇 @ninjani.bsky.social @torstenschwede.bsky.social @unibas.ch @snsf.ch @natureportfolio.nature.com www.biozentrum.unibas.ch/news/detail/...
1mo
Jack Szostak "All of these things frighten me, and they should frighten you as well. I made the decision to create a life for myself here, because I viewed this as a place that rewarded determination, hard work, and integrity. It still has a chance to be that place again."
2mo
Embryogenesis in 4D: a developmental atlas for genes and cells 🧪 @schierlab.bsky.social developed a new method (#weMERFISH) that visualizes the activity of hundreds of genes across the entire zebrafish embryo with subcellular resolution. lnkd.in/eHY5gXDx @erc.europa.eu @snsf.ch @unibas.ch
Prof. Markus Rüegg and Dr. Judith Reinhard joined the Telebasel studio to talk about progress and the ongoing challenges of the gene therapy they’ve developed to treat LAMA2-related muscular dystrophy, a currently incurable and fatal muscle disease affecting children. telebasel.ch/sendungen/pu...
A question I get asked all the time by @dev-journal.bsky.social authors "Why does it cost so much to publish a paper?" We break down the finances and explain where the money goes Spoiler: quality publishing takes a village (people + infrastructure) journals.biologists.com/dev/article/...
2mo
2mo
Developing new medicines is a slow and costly process. For some years now, artificial intelligence (AI) has been considered a promising tool to accelerate drug discovery by identifying drug candidates...
AI models still reach limits in drug discovery
www.biozentrum.unibas.ch
3mo
Attacks on science and immigrants are destroying America.
open.substack.com
I’m a Nobel Prize-winning immigrant. I can no longer recognize this country.
"We want to see the academic publishing industry change in a way that benefits science, not just profits"
Interpretable decoding of cell fate from a snapshot of combinatorial signaling https://www.biorxiv.org/content/10.64898/2026.05.17.725652v1
It's out! Happy to present ITEC, a semi supervised algorithm with an extremely low error rate that can track cells in files of any size (think Terabytes!). We used it in many organisms, including zebrafish, to study how organs form and linked it to gene expression www.biorxiv.org/content/10.6... +🧪
Biozentrum, University of Basel
Ungefähr jedes Jahr wird in der Schweiz ein Kind mit einer schweren Muskelschwäche geboren. LAMA2-Muskeldystrophie ist unheilbar. Nun haben Forschende am…
telebasel.ch
For many of us who work in scientific publishing, the title of this Editorial is a question we hear all the time when we're out talking to academics. And it's a perfectly reasonable one. After all, re...